Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Picroliv holds therapeutic potential
Picroliv has demonstrated improved re-epithelialization, neovascularization and migration of endothelial, dermal myofibroblasts and fibroblasts into the wound bed in a rat model. The findings suggest that the compound, derived from a plant that grows in the Himalayas, holds therapeutic potential as a pro-angiogenic agent in wound healing.
Related Videos
Related Content
